INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

76,369 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
DA
Di Beasi AlisaSVP and CHRO
PHINPHINIA INC.
Grant or award
A—
47 sh
Jun 23, 2026Jun 25, 2026
Page 769 of 1910
← PrevNext →
traded Jun 23, 2026
+2d
SEC Form 4

Evidence

9
GP
Gropp Chris PSenior Vice President and CFO
PHINPHINIA INC.
Grant or award
A—
6 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

9
NS
Noble Ryan S.SVP, Sales & Marketing Dev
KEQUKEWAUNEE SCIENTIFIC CORP /DE/
Grant or award
A—
2,628 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

9
GK
Gefen Lynn KChief People and Legal Officer
TSNDFTerrAscend Corp.
Grant or award
A—
281.3K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

9
GZ
Ghanem ZiadPresident and CEO
TSNDFTerrAscend Corp.
Disposition to issuer
D—
350.0K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

7
AI
Alclear Investments, LLCDirector, 10% Owner, See Remarks
YOUClear Secure, Inc.
Grant or award · 10b5-1 plan
A—
196.6K sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC Form 4

Evidence

7
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$136K
15.6K sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC Form 4

Evidence

7
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M$97K
13.3K sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC Form 4

Evidence

6
BD
Brown Christopher D.Director
MASS908 Devices Inc.
Open-market sale · 10b5-1 plan
SELL$89K
9,900 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
MA
Mendelsohn AaronDirector
VANIVivani Medical, Inc.
Grant or award
A$45K
36.5K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

5
MF
Mills Jason FahrDirector
EXFYExpensify, Inc.
Grant or award
A—
1.16M sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
LA
Leggett Michael AdamSr VP & Chief Supply Chain Off
LZBLA-Z-BOY INC
Tax withholding
F$21K
526 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
GT
Gardner Donald T. IIIChief Financial Officer
KEQUKEWAUNEE SCIENTIFIC CORP /DE/
Grant or award
A—
5,428 sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

5
VG
Vasquez Alison GautEVP AND CFO
ORNOrion Group Holdings Inc
Tax withholding
F$36K
2,325 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
FN
Fryer NeilVP and GM Global Aftermarket
PHINPHINIA INC.
Grant or award
A—
34 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
PS
Pombier SamanthaVice President and Controller
PHINPHINIA INC.
Grant or award
A—
11 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
YH
Yang HongyongVP and GM Fuel Syst. Asia Pac
PHINPHINIA INC.
Grant or award
A—
4 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
CJ
Cordella Richard James JRDirector
MVBFMVB FINANCIAL CORP
Option exercise
M—
3,701 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
WG
Williams GreggDirector, 10% Owner
VANIVivani Medical, Inc.
Grant or award
A$45K
36.5K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

5
CM
Coetzee MichaelVP and GM Fuel Syst. Americas
PHINPHINIA INC.
Grant or award
A—
33 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
VD
Vidal DanielDirector
EXFYExpensify, Inc.
Grant or award
A—
1.16M sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
ML
McCurry Jennifer LynnChief Accounting Officer
LZBLA-Z-BOY INC
Tax withholding
F$8,100
201 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
HD
Hull Thomas David IiiDirector, President & CEO
KEQUKEWAUNEE SCIENTIFIC CORP /DE/
Grant or award
A—
15.2K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

5
SR
Schaffer RyanDirector, Chief Financial Officer
EXFYExpensify, Inc.
Grant or award
A—
1.16M sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
BJ
Bisharat JalehDirector
WLTHWEALTHFRONT CORP
Grant or award
A—
19.4K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
GC
Gustanski ChristopherVP, Operational Excellence
PHINPHINIA INC.
Grant or award
A—
25 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

5
GJ
Garnett Timothy JohnDirector
MPLTMapLight Therapeutics, Inc.
Grant or award
A—
14.9K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

4
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
880.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

4
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
880.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

3
BS
Bizily ScottChief Legal Officer
FDMT4D Molecular Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
9,810 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

2
BM
Barrett David MichaelDirector, Chief Executive Officer
EXFYExpensify, Inc.
Grant or award
A—
2.09M sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

1
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$54K
1,799 sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Option exercise · 10b5-1 plan
M—
660.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
47.5K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

0
Silbermann BenjaminDirector, 10% Owner
PINSPINTEREST, INC.
Derivative conversion · 10b5-1 plan
C—
46.9K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

0
AI
Alclear Investments, LLCDirector, 10% Owner, See Remarks
YOUClear Secure, Inc.
Disposition to issuer · 10b5-1 plan
D—
16.0K sh
Jun 24, 2026Jun 25, 2026
traded Jun 24, 2026
+1dSEC Form 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

0
SM
Schlosser MarioDirector
OSCROscar Health, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jun 23, 2026Jun 25, 2026
traded Jun 23, 2026
+2dSEC Form 4

Evidence

0
AI
Alclear Investments, LLCDirector, 10% Owner, See Remarks
YOUClear Secure, Inc.
Disposition to issuer · 10b5-1 plan
D—
196.6K sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC Form 4

Evidence

0
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Option exercise · 10b5-1 plan
M—
15.6K sh
Jun 25, 2026Jun 25, 2026
traded Jun 25, 2026
+0dSEC Form 4

Evidence